EXPERIENCE AND REASON |
Division of Pediatric Endocrinology and Metabolism
Department of Pediatric and Adolescent Medicine
Mayo Clinic
Rochester, MN 55905
Division of Child and Adolescent Neurology
Department of Pediatrics and Neurology
Mayo Clinic
Rochester, MN 55905
Division of Rheumatology
Department of Pediatrics and Medicine
Mayo Clinic
Rochester, MN 55905
Division of Community Pediatric and Adolescent Medicine
Department of Pediatric and Adolescent Medicine
Mayo Clinic
Rochester, MN 55905
Abbreviations: MRI, magnetic resonance imaging SPECT, single-photon emission computed tomography TSH, thyroid-stimulating hormone EEG, electroencephalogram background activity TPO, thyroperoxidase CSF, cerebrospinal fluid SREHT, steroid responsive encephalopathy associated with Hashimotos thyroiditis
| The first 300 words of the full text of this article appear below. |
We describe the case of a 14-year-old girl who presented with a 5-year history of hallucinations and depression. She had significantly elevated thyroperoxidase (TPO) antibody titers consistent with the diagnosis of Hashimotos thyroiditis. A magnetic resonance imaging (MRI) scan of the brain showed white matter changes affecting the frontal lobe, and cerebral hypoperfusion deficits were observed on serial single-photon emission computed tomography (SPECT) scans. The patient had significant clinical improvement and showed resolution on neuroimaging after corticosteroid treatment. Steroid responsive encephalopathy associated with Hashimotos thyroiditis (SREHT) is a more accurate description of the previously named "Hashimotos encephalopathy." This is a condition with neuropsychiatric symptoms associated with high anti-thyroid antibody titers which shows marked improvement following corticosteroid treatment.
The medical evaluation of adolescents who present with psychiatric symptoms requires a full clinical assessment to exclude organic disease. The list of potential etiologies in these patients can be long, particularly if presenting symptoms do not fall into recognized patterns. We present the case of an adolescent with recent disclosure of long-standing hallucinations and depression who was found to have elevated thyroid-stimulating hormone (TSH) and anti-thyroid antibody titers. This case reinforces the importance of evaluating thyroid function in pediatric patients who present with ill-defined neuropsychiatric symptoms.
| CASE REPORT |
|---|
After normal electroencephalogram background activity (EEG), the patient was treated with numerous psychotropic medications over a 6-month period by her psychiatrist including valproic acid, sertraline, and quetiapine fumarate. These medications reduced the intensity, but not the frequency, of her hallucinations
Address correspondence to Farid H. Mahmud, MD, Mayo Clinic, 200 First St SW, Rochester, MN 55905. E-mail: mahmud.farid@mayo.edu
This article has been cited by other articles:
![]() |
P. Castillo, B. Woodruff, R. Caselli, S. Vernino, C. Lucchinetti, J. Swanson, J. Noseworthy, A. Aksamit, J. Carter, J. Sirven, et al. Steroid-Responsive Encephalopathy Associated With Autoimmune Thyroiditis Arch Neurol, February 1, 2006; 63(2): 197 - 202. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Watemberg, D. Greenstein, and A. Levine Topical Review: Encephalopathy Associated With Hashimoto Thyroiditis: Pediatric Perspective J Child Neurol, January 1, 2006; 21(1): 1 - 5. [Abstract] [PDF] |
||||
![]() |
S Jacob and Y A Rajabally Hashimoto's encephalopathy: steroid resistance and response to intravenous immunoglobulins J. Neurol. Neurosurg. Psychiatry, March 1, 2005; 76(3): 455 - 456. [Full Text] [PDF] |
||||
![]() |
N. S. Hussain, J. Rumbaugh, D. Kerr, A. Nath, and A. E. Hillis Effects of prednisone and plasma exchange on cognitive impairment in Hashimoto encephalopathy Neurology, January 11, 2005; 64(1): 165 - 166. [Full Text] [PDF] |
||||